Ernest Richard Keske

Title: **Ernest Richard Keske: Innovator in Pharmaceutical Processes**

Introduction

Ernest Richard Keske is a notable inventor based in Waukegan, IL, recognized for his contributions to pharmaceutical innovations. With a total of two patents under his name, his work primarily focuses on processes related to drug formulation and production.

Latest Patents

Among his latest patents, one significant invention is the **Process for Aqueous Granulation of Clarithromycin**. This innovative process encompasses mixing a macrolide antibiotic with a carbomer, wetting the mixture with water, and blending it to facilitate the formation of a macrolide antibiotic-carbomer granule. This method enhances product stability and efficacy.

Another noteworthy patent is the **Method of Producing Tablets**. This patent describes dietetic formulations for oral use, specifically tablets created from dense granules of keto- or hydroxy-amino acid analogs. The invention includes processes for maintaining coordinated pressure for extended periods, leading to effective tableting and possible coating of the granules, which enhances their dissolution in gastrointestinal juices.

Career Highlights

Ernest works at Abbott Laboratories Corporation, a global leader in health care, where he applies his innovative spirit to develop advanced pharmaceutical solutions. His expertise contributes to the company’s commitment to improving patient health and wellness.

Collaborations

Throughout his career, Ernest has collaborated with esteemed colleagues, including Azita Saleki-Gerhardt and Kurt G Van Scoik. Their joint efforts in research and development have fostered an environment of innovation, leading to significant advancements in drug formulations.

Conclusion

Ernest Richard Keske’s contributions to pharmaceutical science through his patents underline the importance of innovation in the healthcare sector. His work not only emphasizes the role of skilled inventors in advancing technology but also showcases the collaborative spirit that drives progress within leading research institutions like Abbott Laboratories Corporation.